Revita® is a dehydrated full-thickness placental membrane allograft intended for use as a wound covering and barrier membrane.
• First placental membrane allograft to preserve all three native layers of the tissue: the amnion, the intermediate layer, and the chorion
• Proprietary processing method, Clearify, delivers an optimized tissue allograft which preserves more of the native 3D architecture and intrinsic biological components than the previous generation of amniotic tissue allografts
• By preserving the intermediate layer, more structural components like collagen and hyaluronic acid are maintained
Revita® is to be used as a wound covering, or barrier membrane, over chronic and acute wounds, including dermal ulcers or defects.
Do not use Revita® on any wound with evidence of active, latent infection or gangrene.
Do not use Revita® on compromised patients where the patient's condition may create an unacceptable risk of post-operative infection or complications.
Revita® is for single patient use only. Do not sterilize or re-sterilize. Wounds treated with Revita® should be monitored for signs of infection and treated according to standard practice should infection occur post-transplantation.
Store at ambient temperature. Keep away from excessive heat. Do not freeze.
No current adverse effects or reactions attributed to the Revita® allograft.
The Revita® allograft should be maintained in its original packaging and stored at ambient temperature (0°C-38°C) until ready for use. When stored properly in their original packaging, Revita® allografts are shelf-stable for up to five years.
|Assigned HCPCS code||●|
|Shelf life greater than 2 years||●|
|Shelf life limited||●|
|Indicated for acute wounds||●|
|Indicated for chronic wounds||●|
|Indicated for diabetic ulcers||●|
|Indicated for pressure ulcers||●|
|Indicated for surgical wounds||●|
|Indicated for third-degree burns|
|Indicated for venous ulcers||●|
|Contact manufacturer for usage guidelines||●|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available|
Moderate/Highly Exudating Wounds
Non/Minimally Exudating Wounds
Remove Revita® from the sterile packaging by peeling open the outer peel pouch using the chevron opening. Present the inner, sterile peel pouch into the sterile field. Peel open the sterile pouch and aseptically extract the membrane from the package. Revita® may be applied over the wound area either wet or dry. If rehydration is desired, apply several drops of sterile saline solution at one- to two-minute intervals until the desired level of rehydration is achieved. Apply Revita® directly to the prepared wound bed, ensuring contact with the wound bed. To discourage allograft displacement following transplantation, Revita® may be affixed to the surgical site using aseptic technique with a variety of wound closure mechanisms including absorbable sutures, non-absorbable sutures and/or tissue adhesive appropriate for the wound type.
StimLabs, LLC is a leader in regenerative technologies, with an extensive product pipeline, a portfolio of intellectual property and a suite of placental-derived products.